Cargando…
Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585196/ https://www.ncbi.nlm.nih.gov/pubmed/37853949 http://dx.doi.org/10.1002/ctm2.1450 |
_version_ | 1785122902803218432 |
---|---|
author | Li, Lifeng Sun, Shilong Peng, Mengle Wu, Kai Duan, Xiaoran Xue, Ruyue Yang, Meijia Zhang, Xu Zhao, Jie |
author_facet | Li, Lifeng Sun, Shilong Peng, Mengle Wu, Kai Duan, Xiaoran Xue, Ruyue Yang, Meijia Zhang, Xu Zhao, Jie |
author_sort | Li, Lifeng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10585196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105851962023-10-20 Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma Li, Lifeng Sun, Shilong Peng, Mengle Wu, Kai Duan, Xiaoran Xue, Ruyue Yang, Meijia Zhang, Xu Zhao, Jie Clin Transl Med Letter to the Journal John Wiley and Sons Inc. 2023-10-19 /pmc/articles/PMC10585196/ /pubmed/37853949 http://dx.doi.org/10.1002/ctm2.1450 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Journal Li, Lifeng Sun, Shilong Peng, Mengle Wu, Kai Duan, Xiaoran Xue, Ruyue Yang, Meijia Zhang, Xu Zhao, Jie Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma |
title | Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma |
title_full | Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma |
title_fullStr | Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma |
title_full_unstemmed | Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma |
title_short | Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma |
title_sort | identification and validation of gaba‐driven subtypes and prognosis signature of lung adenocarcinoma |
topic | Letter to the Journal |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585196/ https://www.ncbi.nlm.nih.gov/pubmed/37853949 http://dx.doi.org/10.1002/ctm2.1450 |
work_keys_str_mv | AT lilifeng identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT sunshilong identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT pengmengle identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT wukai identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT duanxiaoran identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT xueruyue identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT yangmeijia identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT zhangxu identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma AT zhaojie identificationandvalidationofgabadrivensubtypesandprognosissignatureoflungadenocarcinoma |